2026-05-28T09:33:41Zhttps://riuma.uma.es/rest/oai/request

oai:riuma.uma.es:10630/311912026-02-03T10:52:39Zcom_10630_2254col_10630_37953

https://hdl.handle.net/10630/31191/ore.xml 2024-05-02T10:32:23Z 2024-05-02T10:32:23Z RIUMA. Repositorio Institucional de la Universidad de Málaga Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study. Pivot, X. Verma, S. Fallowfield, L. Müller, M. Lichinitser, M. Jenkins, V. Sánchez-Muñoz, Alfonso Machackova, Z. Osborne, S. Gligorov, J. 2024-05-02T10:32:23Z ORIGINAL CC-LICENSE LICENSE THUMBNAIL